[HTML][HTML] Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement
R Guo, M Xie, WY Yim, W Wu, W Jiang, Y Wang… - BMC Cardiovascular …, 2021 - Springer
Background Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
[HTML][HTML] Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement
R Guo, M Xie, WY Yim, W Wu… - BMC …, 2021 - bmccardiovascdisord.biomedcentral …
Transcatheter aortic valve replacement (TAVR) has gained increasing acceptance for
patients with aortic disease. Both transfemoral (TF-TAVR) and transapical (TA-TAVR) …
patients with aortic disease. Both transfemoral (TF-TAVR) and transapical (TA-TAVR) …
Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement.
R Guo, M Xie, WY Yim, W Wu, W Jiang… - BMC Cardiovascular …, 2021 - go.gale.com
Background Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
Dose approach matter? A Meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement
R Guo, M Xie, WY Yim, W Wu, W Jiang, Y Wang, X Hu - 2020 - researchsquare.com
Background: Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement
R Guo, M Xie, WY Yim, W Wu… - BMC …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement.
R Guo, M Xie, WY Yim, W Wu, W Jiang… - BMC Cardiovascular …, 2021 - europepmc.org
Background Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement.
R Guo, M Xie, WY Yim, W Wu, W Jiang, Y Wang, X Hu - 2021 - cabidigitallibrary.org
Background: Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
[PDF][PDF] Dose approach matter? A Meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement
R Guo, M Xie, WY Yim, W Wu, W Jiang, Y Wang, X Hu - scholar.archive.org
Background: Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
[HTML][HTML] Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement
R Guo, M Xie, WY Yim, W Wu, W Jiang… - BMC Cardiovascular …, 2021 - ncbi.nlm.nih.gov
Background Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement
R Guo, M Xie, WY Yim, W Wu, W Jiang… - BMC Cardiovascular …, 2021 - search.proquest.com
Background Transcatheter aortic valve replacement (TAVR) has gained increasing
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …
acceptance for patients with aortic disease. Both transfemoral (TF-TAVR) and transapical …